Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

New treatments improved blood pressure control in patients with resistant hypertension.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

A woman's sudden hair loss was linked to azathioprine use despite normal enzyme levels, and improved after stopping the drug and starting treatment.

Minoxidil lowers blood pressure in kids with kidney issues, but use carefully due to side effects.

Tamsulosin is a cost-effective treatment for BPH symptoms.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Higher nitric oxide synthase levels in the scalp may influence hair loss in androgenetic alopecia.

Forsythiaside A reduces kidney damage from sepsis by lowering inflammation and cell death.

Methylene blue can effectively treat severe low blood pressure from minoxidil overdose when standard treatments fail.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Low PON1 levels may indicate and predict the severity of hair loss.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

A 36-year-old woman with low potassium levels was found to have Cushing disease, and after treatment, her potassium levels normalized.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

The girl's swelling and skin issues improved with fluid restriction and diuretics.

Hemodialysis successfully treated a cat with minoxidil poisoning.